Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

Blood

Volumn 85, Issue 11, 1995, Pages 3048-3057

  Dunbar, Cynthia E ^a   Cottler Fox, Michelle ^b   O'Shaughnessy, Joyce A ^b   Doren, Sandra ^b   Carter, Charles ^b   Berenson, Ronald ^b   Brown, Sherri ^b   Moen, Robert C ^b   Greenblatt, Jay ^b   Stewart, F Marc ^b   Leitman, Susan F ^b   Wilson, Wyndham H ^b   Cowan, Kenneth ^b   Young, Neal S ^b   Nienhuis, Arthur W ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CELL LINE; CLINICAL ARTICLE; GENE THERAPY; GENE TRANSFER; GRAFT SURVIVAL; HUMAN; HUMAN CELL; MARKER GENE; MULTIPLE MYELOMA; PRIORITY JOURNAL; VIRUS GENE;

EID: 0029068059     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.11.3048.bloodjournal85113048     Document Type: Article

References (50)

1. Mulligan RC: The basic science of gene therapy. Science 260:926, 1993
2. Miller AD: Human gene therapy comes of age. Nature 357:455, 1992
3. Karlsson S: Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 78:2481, 1991
4. Dunbar CE, Emmons RVB: Gene transfer into hematopoietic progenitor and stem cells: Progress and problems. Stem Cells 12:563, 1994
5. Szilvassy SJ, Fraser CC, Eaves CJ, Lansdorp PM, Eaves AC, Humphries RK: Retrovirus-mediated gene transfer to purified hemopoietic stem cells with long-term lympho-myelopoietic repopulating ability. Proc Natl Acad Sci USA 86:8798, 1989
6. Bodine DM, McDonagh KT, Seidel NE, Nienhuis AW: Survival and retrovirus infection of murine hematopoietic stem cells in vitro: Effects of 5-FU and method of infection. Exp Hematol 19:206, 1991
7. Wilson JM, Danos O, Grossman M, Raulet DH, Mulligan RC: Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci USA 87:439, 1990
8. Lim B, Apperly JF, Orkin SH, Williams DA: Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells. Proc Natl Acad Sci USA 86:8892, 1989
9. Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, Nienhuis AW: Selection of drug resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257:99, 1992
10. Correll PH, Colilla S, Dave HP, Karlsson S: High levels of human glucocerebrosidase activity in macrophages of long-term reconstituted mice after retroviral infection of hematopoietic stem cells. Blood 80:331, 1992
11. Schuening FG, Storb R, Stead RB, Goehle S, Nash R, Miller AD: Improved retroviral transfer of genes into canine hematopoietic progenitor cells kept in long-term marrow culture. Blood 74:152, 1989
12. Carter RF, Abrams-Ogg ACG, Dick JE, Kruth SA, Valli VE, Kamel-Reid S, Dube ID: Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 79:356, 1992
13. Schuening FG, Kawahara K, Miller AD, To R, Goehle S, Stewart D, Mullally K, Fisher L, Graham TC, Appelbaum FR, Hackman R, Osborne WRA, Storb R: Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs. Blood 78:2568, 1991
14. Van Beusechem VW, Kukler A, Heidt PJ, Valerio D: Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci USA 89:7640, 1992
15. + bone marrow cells. Blood 82:1975, 1993
16. Nolta JA, Kohn DB: Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1:257, 1990
17. Hughes PFD, Thacker JD, Hogge D, Sutherland HJ, Thomas TE, Lansdorp PM, Eaves CJ, Humphries RK: Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures. J Clin Invest 89:1817, 1992
18. Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW: Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture initiating cells. Blood 79:1393, 1992
19. Dunbar CE, Nienhuis AW, Stewart FM, Quesenberry P, O'Shaughnessy J, Cowan K, Cottler-Fox M, Leitman S, Goodman S, Sorrentino BP: Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer. Hum Gene Ther 4:205, 1993
20. Stewart FM, Temeles D, Lowry P, Thraves T, Grosh WW, Quesenberry PJ: Post-5-fluorouracil human marrow: Stem cell characteristics and renewal properties after autologous transplantation. Blood 81:2283, 1993
21. Areman EM, Cullis H, Spitzer T, Sacher RA: Automated processing of human bone marrow can result in a population of mononuclear cells capable of achieving engraftment following transplantation. Transfusion 31:724, 1991
22. + marrow cells in patients with breast cancer or neuroblastoma. Blood 77-1717, 1991
23. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986
24. Cassel A, Cottler-Fox M, Doren S, Dunbar CE: Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol 21:585, 1993
25. Cornetta K, Morgan RA, Anderson WF: Safety issues related to retroviral-mediated gene transfer to humans. Hum Gene Ther 2-5 1991
26. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeld M, Moen R: Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125, 1992
27. Bodine DM, McDonagh KT, Brandt SJ, Ney PA, Agricola B, Byrne E, Nienhuis AW: Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci USA 87:3738, 1990
28. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
29. Vescio RA, Hong CH, Cao J, Kim A, Schiller GJ, Lichtenstein AK, Berenson RJ, Berenson JR: The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 84:3283, 1994
30. + hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation. Exp Hematol 23:230, 1995
31. Eaves CJ: Peripheral blood stem cells reach new heights. Blood 82:1957, 1993
32. Lowry PA, Tabara IA: Peripheral hematopoietic stem cell transplantation: Current concepts. Exp Hematol 20:937, 1992
33. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609, 1994
34. Kessinger A: Autologous transplantation with peripheral blood stem cells: A review of clinical results. J Clin Apheresis 5:97, 1990
35. Kessinger A, Smith DM, Strandjord SE, Landmark JD, Dooley DC, Law P, Coccia PF, Warkentin PI, Weisenburger DD, Armitage JO: Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 4:643, 1989
36. Brito-Babapulle F, Bowcock SJ, Marcus RE, Apperley J, Th'ng KH, Dowding C, Rassool F, Guo A-P, Catovsky D, Galton DAG, McCarthy D, Goldman JM: Autografting for patients with chronic myeloid leukaemia in chronic phase: Peripheral blood stem cells may have a finite capacity for maintaining haematopoiesis. Br J Haematol 73:76, 1989
37. Baumann I, Testa NG, Lange C, De Wynter E, Luft T, Dexter TM, Van Hoef MEHM, Howell A: Haemopoietic cells mobilized into the circulation by lenograstim as an alternative to bone marrow for allogeneic transplants. Lancet 341:369, 1993
38. Bregni M, Magni M, Siena S, Di Nicola M, Bonadonna G, Gianni AM: Human peripheral blood hematopoietic progenitors are optimal targets of retroviral mediated gene transfer. Blood 80:1418, 1992
39. Kiem H-P, Darovsky B, von Kalle C, Goehle S, Stewart D, Graham T, Hackman R, Appelbaum FR, Deeg HJ, Miller AD, Storb R, Schuening FG: Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells. Blood 83:1467, 1994
40. Pettengell R, Testa NG, Swindell R, Crowther D, Dexter TM: Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 82:2239, 1993
41. Sutherland HJ, Eaves CJ, Lansdorp PM, Phillips GL, Hogge DE: Kinetics of committed and primitive blood progenitor mobilizations after chemotherapy and growth factor treatment and their use in autotransplant. Blood 83:3808, 1994
42. Stewart FM, Crittenden RB, Lowry PA, Pearson-White S, Quesenberry PJ: Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 81:2544, 1993
43. Wu D-d, Keating A: Hematopoietic stem cells engraft in untreated transplant recipients. Exp Hematol 21:251, 1993
44. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341:85, 1993
45. Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994
46. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation in CML. Blood 83:3068, 1994
47. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
48. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
49. Kantoff PW, Gillio AP, McLachlin JR, Bordignnon C, Eglitis MA, Kernan NA, Moen RC, Kohn DB, Yu SF, Karson E, Karlsson S, Zweibel J, Gilboa E, Blaese RM, Neinhuis A, O'Reilly RJ, Anderson WF: Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. J Exp Med 166:219, 1987
50. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest 93:1451, 1994